Xiaofeng Lv Selected Research

Xiaofeng Lv Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 11/2022 - 04/2012
5	Hypoglycemia (Reactive Hypoglycemia) 09/2017 - 12/2013
4	Weight Gain 03/2019 - 03/2015
4	Body Weight (Weight, Body) 09/2017 - 04/2012
3	Diabetes Mellitus 11/2022 - 12/2012
3	Breast Neoplasms (Breast Cancer) 07/2012 - 03/2012
2	Sepsis (Septicemia) 01/2022 - 03/2019
2	Neoplasms (Cancer) 03/2020 - 12/2019
2	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2018 - 05/2014
2	Diarrhea 01/2016 - 01/2015
2	Cerebral Infarction 01/2015 - 07/2014
1	Liver Diseases (Liver Disease) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 03/2020
1	Ovarian Epithelial Carcinoma 03/2020
1	Pre-Eclampsia (Preeclampsia) 01/2020
1	Premature Birth (Birth, Premature) 01/2020
1	Hirschsprung Disease (Hirschsprung's Disease) 01/2020
1	Carcinogenesis 12/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019
1	Disease Progression 12/2019
1	Inflammation (Inflammations) 03/2019
1	Pain (Aches) 03/2018
1	Abdominal Hernia (Abdominal Hernias) 03/2016
1	Infections 03/2016
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Cholestasis 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Weight Loss (Weight Reduction) 11/2014
1	Nausea 11/2014
1	Stroke (Strokes) 07/2014
1	Pleural Effusion (Pleural Effusions) 04/2013
1	Osteolysis 04/2013
1	Osteoporosis 01/2013
1	Bone Resorption 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2012
1	Hypercholesterolemia 04/2012

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 11/2022 - 04/2012
7	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 11/2014
5	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2013
5	Blood Glucose (Blood Sugar)IBA 11/2022 - 04/2012
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2022 - 04/2012
2	LipidsIBA 01/2022 - 04/2012
2	Glucagon-Like Peptide-1 ReceptorIBA 12/2020 - 11/2014
2	AlbuminsIBA 01/2018 - 12/2012
2	Insulin Glargine (Lantus)FDA Link 06/2016 - 04/2012
2	VildagliptinIBA 05/2016 - 03/2015
2	HDL LipoproteinsIBA 07/2012 - 03/2012
1	Insulin Aspart (NovoLog)FDA Link 11/2022
1	polyethylene glycol loxenatideIBA 12/2020
1	eosinylphosphatidylethanolamine (EOPE)IBA 01/2020
1	Chemokine Receptor D6IBA 01/2020
1	Circular RNAIBA 12/2019
1	Sincalide FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Untranslated RNA (Noncoding RNA)IBA 12/2019
1	BilirubinIBA 03/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2019
1	InterleukinsIBA 03/2019
1	Alanine Transaminase (SGPT)IBA 03/2019
1	CytokinesIBA 03/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2019
1	Pregabalin (Lyrica)FDA Link 03/2018
1	DorzagliatinIBA 01/2018
1	saxagliptin FDA Link 01/2018
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018
1	GlucosidasesIBA 01/2018
1	Acarbose FDA LinkGeneric 09/2017
1	insulin degludecIBA 06/2016
1	glimepiride (Amarel)FDA LinkGeneric 03/2015
1	oxidized low density lipoproteinIBA 01/2015
1	lixisenatideIBA 11/2014
1	NAD (NADH)IBA 05/2014
1	Thioctic Acid (Lipoic Acid)IBA 05/2014
1	AcidsIBA 04/2013
1	LeptinIBA 01/2013
1	Propranolol (Inderal)FDA LinkGeneric 01/2013
1	Hormones (Hormone)IBA 07/2012
1	Hypochlorous Acid (Hypochlorite)IBA 03/2012

Therapy/Procedure

6	Therapeutics 12/2020 - 12/2013
5	Glycemic Control 11/2022 - 03/2015
3	Operative Time 03/2016 - 01/2015
3	Length of Stay 01/2016 - 01/2015
1	Catheters 01/2022
1	Parenteral Nutrition 01/2022
1	Neoadjuvant Therapy 03/2020
1	Ileostomy 01/2020
1	Colostomy 01/2020
1	Radiotherapy 04/2013
1	Ovariectomy (Oophorectomy) 01/2013